-
- Posted Wednesday October 23, 2013
Former U.S. Vice President Dan Quayle elected to TGen Foundation Board of Directors
Arizona resident brings national recognition, vast political experience and international financial savvy to non-profit engine of biomedical research
PHOENIX, Ariz. - Oct. 23, 2013 - Former U.S.
Vice President Dan Quayle, who served under President George H.W.
Bush from 1989-93, was elected today to the Board of Directors of
the TGen Foundation, the philanthropic arm of the non-profit
Translational Genomics Research Institute (TGen).
Vice President Quayle attended grade school and high school in
Phoenix and Scottsdale and he and his wife, Marilyn, are now
residents of Paradise Valley. He brings to the TGen Foundation his
vast career experience in politics and financial investment.
"It is my honor to be selected to be a part of TGen and the
phenomenal work this biomedical institute is doing to find better
treatments for the most serious diseases affecting humanity," said
Quayle, who also is a former U.S. representative and senator from
Indiana, and who today is chairman of Cerberus Global Investments,
a private equity company with $25 billion under management.
TGen Foundation Board Chairman
Bennett Dorrance welcomed Quayle, noting that he is instantly one
of the best known among a cadre of top-flight Arizonans who serve
on the non-profit panel.
"Today we welcome Vice President Dan Quayle to our TGen family
with high expectations and confidence that he will further enhance
our philanthropic reach across the nation and help fuel TGen's
genomic research of the world's most pressing diseases," Dorrance
said. "We welcome his involvement, his extraordinary relationships
and his business acumen."
Dr. Jeffrey Trent, TGen President and Research Director, also
welcomed Quayle, whose term as Vice President (1989-1993) coincided
with Dr. Trent serving as Scientific Director of the National Human
Genome Research Institute at the National Institutes of Health
(NIH) in Bethesda, Maryland.
"In 1990, the NIH and the Department of Energy joined with
international partners in a quest to sequence all 3 billion letters
in the human genome. Vice President Quayle is acutely aware of the
importance of this public effort, and remains an advocate for
genomic research and what it means for our patients," Dr. Trent
said.
TGen Foundation President Michael Bassoff said that the addition
of Quayle to the TGen Foundation Board of Directors would
undoubtedly be of huge importance to the future of the
institute.
"He brings a powerful internationally recognized voice to advance
TGen's scientific research," Bassoff said.
Quayle graduated from DePauw University in 1969, and received his
law degree from Indiana University in 1974.
He was first elected to the U.S. House of Representatives in 1976
at age 29; to the U.S. Senate in 1980 at age 33; and Vice President
of the United States in 1988 at age 41, during which he made
official visits to 47 nations and served as chairman of the
National Space Council. He has authored three books, including
Standing Firm, a vice-presidential memoir, which was on
The New York Times best-seller list for 15 weeks.
Quayle also was a distinguished visiting professor of
international studies at Thunderbird, The American Graduate School
of International Management in Glendale, Arizona.
At Cerberus, one of the world's leading investment firms, he has
been actively involved in new business sourcing and marketing in
North America, Europe and Asia. His extensive global network of
public and private sector decision-makers, combined with his
investment expertise, has significantly contributed to the growth
of Cerberus.
# # #
About TGen
Translational Genomics Research Institute (TGen) is a Phoenix,
Arizona-based non-profit organization dedicated to conducting
groundbreaking research with life changing results. TGen is focused
on helping patients with cancer, neurological disorders and
diabetes, through cutting edge translational research (the process
of rapidly moving research towards patient benefit). TGen
physicians and scientists work to unravel the genetic components of
both common and rare complex diseases in adults and children.
Working with collaborators in the scientific and medical
communities literally worldwide, TGen makes a substantial
contribution to help our patients through efficiency and
effectiveness of the translational process. For more information,
visit:www.tgen.org.
Press Contact:
Steve Yozwiak
TGen Senior Science Writer
602-343-8704
[email protected]